US2014221451A1PendingUtilityA1
Implants for the treatment of dopamine associated states
Est. expiryApr 6, 2026(expired)· nominal 20-yr term from priority
A61P 43/00A61P 5/00A61P 5/06A61P 25/00A61P 25/16A61P 25/28A61P 25/14A61P 21/00A61P 15/00A61P 15/10A61L 27/34A61L 27/18A61L 31/06A61L 27/54A61L 31/16A61K 31/4045A61L 31/10A61K 9/204A61K 9/0024A61L 31/148A61L 2300/40A61K 31/403A61K 31/517
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Biodegradable implants comprising dopamine modulating compounds are described.
Claims
exact text as granted — not AI-modified1 . A method of treating a subject for a dopamine associated state, comprising administering to said subject a biodegradable implant, wherein said implant comprises an effective amount of a dopamine modulating compound, such that said subject is treated for said dopamine associated state.
2 - 25 . (canceled)
26 . A biodegradable implant, comprising a dopamine modulating compound and a biodegradable polymer.
27 - 42 . (canceled)
43 . A method for maintaining a plasma level of between about 1 and 40 of a dopamine modulating compound in a subject, comprising administering to said subject an implant comprising a biodegradable polymer and said dopamine modulating compound, such that the plasma level of said compound is maintained for at least one day.
44 - 56 . (canceled)
57 . The method of claim 1 , wherein the dopamine associated state is Parkinson's disease, and wherein the dopamine modulating compound is ropinirole.
58 - 59 . (canceled)Join the waitlist — get patent alerts
Track US2014221451A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.